1. Home
  2. SCNI vs AIXI Comparison

SCNI vs AIXI Comparison

Compare SCNI & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SCNI

Scinai Immunotherapeutics Ltd.

HOLD

Current Price

$0.60

Market Cap

2.3M

Sector

Health Care

ML Signal

HOLD

AIXI

XIAO-I Corporation

HOLD

Current Price

$0.12

Market Cap

2.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCNI
AIXI
Founded
2003
2001
Country
Israel
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.3M
2.7M
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
SCNI
AIXI
Price
$0.60
$0.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
42.1K
1.1M
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
50.00
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$26.84
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$0.11
52 Week High
$6.18
$4.40

Technical Indicators

Market Signals
Indicator
SCNI
AIXI
Relative Strength Index (RSI) 28.18 32.98
Support Level N/A N/A
Resistance Level $0.94 $0.39
Average True Range (ATR) 0.06 0.02
MACD -0.01 -0.00
Stochastic Oscillator 22.54 25.25

Price Performance

Historical Comparison
SCNI
AIXI

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

About AIXI XIAO-I Corporation

XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.

Share on Social Networks: